Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC006486.9 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | AC009065.1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | AC009133.23 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | AC015688.3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | AC024361.1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | AC069499.1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | AC087350.1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
mRNA | AC090154.1 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | AC092835.2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
mRNA | AC104534.3 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |